Lost your password? Please enter your email address. You will receive a link and will create a new password via email.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
What are the challenges that early-stage biotech ventures must overcome?
Early-stage biotech ventures face high R&D costs, long development timelines, regulatory hurdles, scientific risks, funding challenges, talent acquisition issues, IP concerns, market acceptance difficulties, partnership needs, manufacturing and scalability problems, and ethical considerations. ORead more
Early-stage biotech ventures face high R&D costs, long development timelines, regulatory hurdles, scientific risks, funding challenges, talent acquisition issues, IP concerns, market acceptance difficulties, partnership needs, manufacturing and scalability problems, and ethical considerations. Overcoming these requires strategic planning, strong leadership, robust funding, and clear commercialization pathways.
See less